Maximo F. Nougues

CIK: 0001758507

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (75.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PBYI

PUMA BIOTECHNOLOGY, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

PBYI
PUMA BIOTECHNOLOGY, INC.
Jul 6, 2026
Sale(S)
Direct
9.4K shares at avg. $8.26$78K
PBYI
PUMA BIOTECHNOLOGY, INC.
Feb 18, 2026
Award(A)
Direct
46.7K shares-
PBYI
PUMA BIOTECHNOLOGY, INC.
Jan 7, 2026
Sale(S)
Direct
6.4K shares at avg. $5.88$38K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jan 6, 2026
Sale(S)
Direct
4.5K shares at avg. $5.84$27K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jul 9, 2025
Sale(S)
Direct
3.9K shares at avg. $3.54$14K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jul 8, 2025
Sale(S)
Direct
5.6K shares at avg. $3.53$20K
PBYI
PUMA BIOTECHNOLOGY, INC.
Feb 7, 2025
Award(A)
Direct
61.5K shares-
PBYI
PUMA BIOTECHNOLOGY, INC.
Jan 2, 2025
Sale(S)
Direct
10.2K shares at avg. $3.15$32K

		Type	Shares	Price		Ownership
Jul 6, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	9,386	$8.26	$77,557	Direct
Feb 18, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Award(A)	46,739	-	$0	Direct
Jan 7, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	6,405	$5.88	$37,655	Direct
Jan 6, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	4,540	$5.84	$26,532	Direct
Jul 9, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	3,935	$3.54	$13,910	Direct
Jul 8, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	5,587	$3.53	$19,739	Direct
Feb 7, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Award(A)	61,456	-	-	Direct
Jan 2, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	10,227	$3.15	$32,232	Direct

1-8 of 8 transactions

About NOUGUES MAXIMO F

NOUGUES MAXIMO F (SEC CIK 0001758507) files insider reports with the SEC as Chief Financial Officer of PUMA BIOTECHNOLOGY, INC. (PBYI).

Signal8 holds 6 ownership filings by NOUGUES MAXIMO F, all Form 4s, filed between Jan 3, 2025 and Jul 8, 2026. Those filings report 8 transactions, from Jan 2, 2025 to Jul 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on NOUGUES MAXIMO F's filings is in LOS ANGELES, CA.

Recent filings by NOUGUES MAXIMO F

Jul 6, 2026: Open-market sale of PBYI shares (Form 4, code S).
Feb 18, 2026: Grant or award of PBYI shares (Form 4, code A).
Jan 7, 2026: Open-market sale of PBYI shares (Form 4, code S).
Jan 6, 2026: Open-market sale of PBYI shares (Form 4, code S).
Jul 9, 2025: Open-market sale of PBYI shares (Form 4, code S).

Other insiders filing for PUMA BIOTECHNOLOGY, INC. (PBYI)

How to read Form 4 transaction codes